The Spanish State Research Agency (AEI) has published three calls for funding aimed at promoting knowledge generation, facilitating the recruitment of postdoctoral researchers, and strengthening technical and research and innovation management teams. The Marqués de Valdecilla Research Institute (IDIVAL) is informing researchers about these opportunities and the internal deadlines established for submitting applications, which will […]
The donation will contribute to research projects focusing on aggressive breast cancer, metastasis and the application of artificial intelligence to clinical research. The Marqués de Valdecilla Research Institute (IDIVAL) has received a €20,000 donation from the association Luchamos por la Vida to support several breast cancer research projects carried out at Marqués de Valdecilla University […]
The Marqués de Valdecilla Research Institute (IDIVAL) hosted Myriam Sainz Ramos, a professional from the Innovation Area of Biobizkaia, for a two-day visit as part of the mobility programme promoted by the Network of Clinical Research Management Entities (REGIC). During her stay, Sainz Ramos had the opportunity to gain first-hand insight into IDIVAL’s work and, […]
The Marqués de Valdecilla Research Institute Foundation (IDIVAL) has obtained ISO 56001:2024 certification, the international standard for innovation management systems. The certificate confirms that IDIVAL’s management system meets the requirements established by this standard for the promotion and management of biomedical research and innovation within Cantabria’s healthcare and biomedical environment. ISO 56001:2024 provides a framework […]
López Hoyos will remain affiliated with the Institute as a researcher and coordinator of Scientific Output, while also contributing to the development of the future Health Innovation Park The Marqués de Valdecilla Research Institute (IDIVAL) is entering a new organisational phase following the decision by its Scientific Director, Marcos López Hoyos, to step down from […]
Published in Progress in Neuro-Psychopharmacology and Biological Psychiatry, the study analyses the relationship between immune response during pregnancy, sociocultural factors and child development following prenatal exposure to SARS-CoV-2. The Mental Health Research Group at the Marqués de Valdecilla Research Institute (IDIVAL) is conducting this longitudinal study, which began during the COVID-19 pandemic. The team will […]
Álvaro Terán and María Moris, endoscopists from the Digestive Diseases Department of the Hospital Universitario Marqués de Valdecilla (HUMV) and researchers at the Instituto de Investigación Marqués de Valdecilla (IDIVAL), participated on 4 and 5 September in a training meeting held in Warsaw (Poland), as part of the European Joint Action EUCanScreen. The activity took […]
The Marqués de Valdecilla Research Institute Foundation (IDIVAL) is participating in the European project PRAISE-U Plus, a new phase of the PRostate cancer Awareness and Initiative for Screening in the European Union, which aims to improve the early detection of prostate cancer through the development and implementation of population-based screening programmes adapted to individual risk. […]
Volunteer recruitment begins The Marqués de Valdecilla University Hospital is participating in a study investigating a seasonal influenza vaccine based on messenger RNA (mRNA) technology (already used in the development of authorised vaccines for other diseases, such as respiratory syncytial virus infection, COVID-19 and influenza itself) in adults aged 65 and over. This trial will […]
The Institute will bring biomedical research closer to the public through three initiatives focused on population research, precision medicine and neuropsychology The 14th European Researchers’ Night will take place in Santander on 25 September, an initiative promoted by the European Union that brings science closer to the public each year through demonstrations, experiments and hands-on […]
